KALA BIO, Inc.
KALA
Peringkat dalam Saham
#30862
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the... Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Harga Saham
$0.75
Terakhir disinkronkan: 2026-07-31
Kapitalisasi Pasar
$14.50M
Perubahan (1 hari)
2.78%
Perubahan (1 tahun)
-98.84%
Negara
US
Perdagangan KALA BIO, Inc. (KALA)
Kategori
Healthcare
Kapitalisasi pasar dari KALA BIO, Inc.(KALA)
Kapitalisasi Pasar: $14.50M
Per October 2026, KALA BIO, Inc. memiliki kapitalisasi pasar sebesar $14.50M. Ini menjadikan KALA BIO, Inc. sebagai perusahaan 30862nd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar KALA BIO, Inc. dari 2018 hingga 2026
KALA dibandingkan dengan 5 teratas stocks paling populer
